Drug profile · INN
edoxaban tosylate
SAVAYSA
edoxaban tosylate (SAVAYSA) is a coagulation factor x inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — edoxaban tosylate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
edoxaban tosylate (SAVAYSA) is a coagulation factor x inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Coagulation factor X inhibitor
Primary target: Coagulation factor X
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is edoxaban tosylate?
edoxaban tosylate (SAVAYSA) is a coagulation factor x inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for edoxaban tosylate?
SAVAYSA is a marketed brand name for edoxaban tosylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of edoxaban tosylate?
edoxaban tosylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.